Skip to main navigation Skip to search Skip to main content

Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy

  • Gianluigi Savarese
  • , Felix Lindberg
  • , Antonio Cannata
  • , Marianna Adamo
  • , Giuseppe Ambrosio
  • , Pietro Ameri
  • , Markus S. Anker
  • , Magnus Bäck
  • , Antoni Bayes-Genis
  • , Tuvia Ben Gal
  • , Frieder Braunschweig
  • , Ovidiu Chioncel
  • , Emilia D'Elia
  • , Hassan El-Tamimi
  • , Gerasimos Filippatos
  • , Nicolas Girerd
  • , Loreena Hill
  • , Ewa Jankowska
  • , Kamlesh Khunti
  • , Basil S. Lewis
  • Brenda Moura, Offer Amir, Stefania Paolillo, Massimo Piepoli, Abdulla Shehab, Maggie Simpson, Hadi Skouri, Davide Stolfo, Carlo Gabriele Tocchetti, Cristiana Vitale, Maurizio Volterrani, Stephan von Haehling, Sven Wassmann, Mehmet Birhan Yilmaz, Juan Carlos Kaski, Dobromir Dobrev, Marco Metra, Giuseppe M.C. Rosano
  • Karolinska Institutet
  • King's College Hospital NHS Foundation Trust
  • University of Brescia
  • University of Perugia
  • Italian National Institute for Cardiovascular Research – INRC
  • University of Genoa
  • San Martino Hospital Genoa
  • Charité – Universitätsmedizin Berlin
  • Université de Lorraine
  • Generalitat de Catalunya
  • Tel Aviv University
  • Carol Davila University of Medicine and Pharmacy
  • Papa Giovanni XXIII Hospital
  • University of Milan - Bicocca
  • Mohammed Bin Rashid University of Medicine and Health Sciences
  • National and Kapodistrian University of Athens
  • Ulster University
  • Wrocław Medical University
  • University of Leicester
  • Technion-Israel Institute of Technology
  • Porto Armed Forces Hospital
  • University of Porto
  • Hadassah University Medical Centre
  • University of Naples Federico II
  • IRCCS Policlinico San Donato
  • University of Milan
  • United Arab Emirates University
  • University of Edinburgh
  • University of Balamand
  • Sheikh Shakhbout Medical City
  • Azienda Sanitaria Universitaria Integrata di Udine
  • IRCCS San Raffaele Pisana - Roma
  • San Raffaele Open University of Rome
  • University of Göttingen
  • German Centre for Cardiovascular Research
  • Saarland University
  • Dokuz Eylul University
  • St. George's University of London
  • University of Duisburg-Essen
  • University of Montreal
  • Baylor College of Medicine
  • University of Rome

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Heart failure (HF) affects over 60 million individuals globally. Contemporary guideline-directed medical therapies (GDMT) reduce cardiovascular mortality and HF hospitalizations. However, medication non-adherence represents a critical barrier limiting real-world efficacy of GDMT. This scientific statement aims to provide a comprehensive framework for understanding, measuring, and addressing medication non-adherence in HF management across diverse healthcare settings. Addressing medication non-adherence requires systematic, multifaceted approaches targeting individual patient barriers while implementing system-level interventions. Polypills, digital monitoring platforms, enhanced patient education and empowerment, and multidisciplinary care models represent promising strategies to optimize therapeutic adherence and improve clinical outcomes in HF management.

Original languageEnglish
Pages (from-to)2716-2731
Number of pages16
JournalEuropean Journal of Heart Failure
Volume27
Issue number12
Early online date9 Nov 2025
DOIs
StatePublished - Dec 2025
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2025 The Author(s). European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Keywords

  • Adherence
  • Digital
  • Education
  • Fixed-dose combinations
  • Guidelines
  • Heart failure
  • Multidisciplinary
  • Polypill

Fingerprint

Dive into the research topics of 'Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy'. Together they form a unique fingerprint.

Cite this